RC
KROS icon

Rangeley Capital’s Keros Therapeutics KROS Stock Holding History

Rangeley Capital’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$3.81M Sell
285,400
-122,834
-30% -$1.64M 4.55% 6
2025
Q1 		$4.16M Buy
+408,234
New +$4.16M 4.46% 6